The DOI matches its Crossref record.
Ventricular fibrillation in the Wolff-Parkinson-White syndrome
Abstract
Ventricular fibrillation (VF) is a well-known but rare complication of the Wolff-Parkinson-White syndrome (WPW). Clinical and electrophysiological data of 23 patients with spontaneous VF were compared with data from 100 consecutive patients with WPW without VF but with symptomatic supraventricular tachycardia. The 23 patients were collected in a multicentre retrospective study in seven European centres. VF occurred in only one patient who was receiving anti-arrhythmic drugs, and was the first manifestation of the syndrome in six. No significant differences were found between those with VF and without VF in age, complaints of palpitations, syncope, and presence of structural heart disease. The retrograde effective refractory period of the accessory pathway, the atrial refractory period and the fastest atrial pacing rate with 1: 1 anterograde conduction over the accessory pathway were similar in both groups. Significant differences were found for sex, permanent pre-excitation on the electrocardiogram, type of documented supraventricular t achy arrhythmias, shortest RR interval ≦220 ms during spontaneous atrial fibrillation (AF), inducibility of supraventricular tachycardias, ventricular effective refractory period ≦190 ms, mean shortest RR interval during induced AF ≦, 180 ms and presence of multiple accessory pathways. Data from this retrospective study indicate that: (1) the anterograde conduction properties of the accessory pathway are a major determinant of the occurrence of VF in the WPW syndrome; (2) other markers for risk of VF are type of previously documented supraventricular tachyarrhythmia, documentation of more than one type of supraventricular tachycardia in the same patient and presence of two or more accessory pathways; (3) the finding of intermittent pre-excitation and a shortest RR interval during spontaneous AF longer than 220 ms, identifies a group of patients at low risk of VF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In early studies, identified predictors of ventricular fibrillation in patients with WPW syndrome were R-R interval during spontaneous or induced AF , 180 ms, history of symptomatic tachycardia and inducibility of AVRT, and multiple accessory pathways.308,309”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [309]
Citations
Cited by
Sorted by citations
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,312
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. G. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 898
Blomström‐Lundqvist, C., Scheinman, M. M., Aliot, E., Alpert, J. S., Calkins, H. G., Camm, A. J., Campbell, W. B., Haines, D. E., Kück, K., Lerman, B. B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.013 · Cited by 684
Self-citationCohen, M. I., Triedman, J. K., Cannon, B. C., Davis, A. M., Drago, F., Janoušek, J., Klein, G. J., Law, I. H., Morady, F., Paul, T., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.03.050 · Cited by 379
“Utilization of invasive risk stratification (transesophageal or intracardiac) to assess the shortest preexcited R-R interval in atrial fibrillation is reasonable in individuals whose noninvasive testing does not demonstrate clear and abrupt loss of preexcitation (Class IIA, Levels of Evidence B/C).(2) 3.”
BackgroundInfluentialAborted sudden death in the Wolff-Parkinson-White syndrome
Timmermans, C., Smeets, J. L. R. M., Rodriguez, L.-M., Vrouchos, G., van den Dool, A., & Wellens, H. J. J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80136-2 · Cited by 274
Self-citationSudden Cardiac Death With Apparently Normal Heart
Chugh, S. S., Kelly, K. L., & Titus, J. L. (2000) · Circulation · doi:10.1161/01.cir.102.6.649 · Cited by 243
Pappone, C., Vicedomini, G., Manguso, F., Saviano, M., Baldi, M., Pappone, A., Ciaccio, C., Giannelli, L., Ionescu, B., Petretta, A., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.011154 · Cited by 212
The Natural History of Asymptomatic Ventricular Pre-Excitation
Santinelli, V., Radinovic, A., Manguso, F., Vicedomini, G., Gulletta, S., Paglino, G., Mazzone, P., Ciconte, G., Sacchi, S., Sala, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.037 · Cited by 204
“In he univariate analysis, tachyarrhythmia inducibility, PERP, and multiple APs at baseline were significantly ssociated with development of life-threatening arrhythmic vents (Table 3).”
BackgroundInfluentialJCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 205
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188
“Analysis of timedependent receiver operating curves for the prediction of VF showed an optimal accessory pathway ERP cut-off point at 240 ms,(322) which confirms the key role of a very short effective refractory period of the accessory pathway to facilitate degeneration of AF into VF.(306,322,335,337) –342 In a recent…”
BackgroundResultSelf-citationPappone, C., Santinelli, V., & Manguso, F. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.12.058 · Cited by 175
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 166
Fitzsimmons, P. J., McWhirter, P. D., Peterson, D. W., & Kruyer, W. B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.117779 · Cited by 156
Age at onset and gender of patients with different types of supraventricular tachycardias
Rodriguez, L.-M., de Chillou, C., Schläpfer, J., Metzger, J., Baiyan, X., van den Dool, A., Smeets, J. L. R. M., & Wellens, H. J. J. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90060-c · Cited by 153
Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome
Etheridge, S. P., Escudero, C. A., Blaufox, A. D., Law, I. H., Dechert-Crooks, B. E., Stephenson, E. A., Dubin, A. M., Ceresnak, S. R., Motonaga, K. S., Skinner, J. R., et al. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.10.009 · Cited by 130
Atrial fibrillation: Maintenance of sinus rhythm versus rate control
Sopher, S. M., & Camm, A. J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89115-1 · Cited by 118
Arnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H. G., Chin, A., Coats, A. J. S., Deharo, J., Svendsen, J. H., Heidbüchel, H., Isa, R., et al. (2019) · EP Europace · doi:10.1093/europace/euz046 · Cited by 127
Wellens, H. J. J. (2005) · Circulation · doi:10.1161/circulationaha.104.483321 · Cited by 113
Self-citationJCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1212 · Cited by 132
Fudge, J. R., Harmon, K. G., Owens, D. S., Prutkin, J. M., Salerno, J. C., Asif, I. M., Haruta, A., Pelto, H. F., Rao, A. L., Toresdahl, B. G., et al. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2014-093840 · Cited by 109
The Treatment of Atrial Fibrillation
Nattel, S., Hadjis, T., & Talajic, M. R. (1994) · Drugs · doi:10.2165/00003495-199448030-00003 · Cited by 102
Self-citationAssociation Between Atrial Fibrillation and Sudden Cardiac Death
Waldmann, V., Jouven, X., Narayanan, K., Piot, O., Chugh, S. S., Albert, C. M., & Marijon, É. (2020) · Circulation Research · doi:10.1161/circresaha.120.316756 · Cited by 91
Santinelli, V., Radinovic, A., Manguso, F., Vicedomini, G., Ciconte, G., Gulletta, S., Paglino, G., Sacchi, S., Sala, S., Ciaccio, C., et al. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.827550 · Cited by 83
“Prior electrophysiology or population-based studies (19-29) have reported that asymptomatic population with ventricular preexcitation, as a whole, has a benign prognosis although it is well known that sudden death can be the first clinical manifestation of the syndrome in a previously asymptomatic subjects (2-5, 8-11).”
BackgroundBrugada, P., Andries, E., Gürsoy, S., & Brugada, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91155-f · Cited by 71
Self-citationAtrial fibrillation in the Wolff-Parkinson-White syndrome
Pietersen, A. H., Andersen, E. D., & Sandøe, E. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91076-g · Cited by 65
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia
Takase, B., Ikeda, T., Shimizu, W., Abe, H., Aiba, T., Chinushi, M., Koba, S., KUSANO, K. F., Niwano, S., Takahashi, N., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0827 · Cited by 68
Wackel, P. L., Irving, C. A., Webber, S. A., Beerman, L. B., & Arora, G. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03518.x · Cited by 59
Moore, J. P., Kannankeril, P. J., & Fish, F. A. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.958660 · Cited by 55
Long-term results of the corridor operation for atrial fibrillation.
van Hemel, N. M., Defauw, J., Kingma, J. H., Jaarsma, W., Vermeulen, F. E. E., de Bakker, J. M. T., & Guiraudon, G. M. (1994) · Heart · doi:10.1136/hrt.71.2.170 · Cited by 51
Evaluation and Management of Wolff-Parkinson-White in Athletes
Rao, A. L., Salerno, J. C., Asif, I. M., & Drezner, J. A. (2013) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738113509059 · Cited by 47
TODD, D. M., Klein, G. J., Krahn, A. D., Skanes, A. C., & Yee, R. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02707-9 · Cited by 47
“In the three largest series of WPW patients with VF published, VF was the initial presenting symptom in 3/25 patients (16), 6/23 patients (17), and 8/15 patients (18).”
BackgroundRisk of Sudden Arrhythmic Death in the Wolff‐Parkinson‐White Syndrome: Current Perspectives
Zardini, M., Yee, R. K., Thakur, R. K., & Klein, G. J. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb01440.x · Cited by 46
The Asymptomatic Patient with the Wolff‐Parkinson‐White Electrocardiogram
Wellens, H. J. J., RODRIGUEZ, L. M., Timmermans, C. C., & Smeets, J. L. R. M. (1997) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1997.tb03633.x · Cited by 42
Self-citationKubuš, P., Vít, P., Gebauer, R., Materna, O., & Janoušek, J. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000930 · Cited by 44
JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12714 · Cited by 41
Supraventricular Tachycardia—Part I
Lee, K. W., Badhwar, N., & Scheinman, M. M. (2008) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2008.06.002 · Cited by 39
Mambro, C. D., Russo, M. S., Righi, D., Placidi, S., Palmieri, R., Silvetti, M. S., Gimigliano, F., PROSPERI, M., & Drago, F. (2014) · EP Europace · doi:10.1093/europace/euu191 · Cited by 38
Mahtani, A. U., & Nair, D. G. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.05.007 · Cited by 39
Long-term results of radiofrequency catheter ablation in patients with multiple accessory pathways
Huang, J., Shih-Ann, C., Ching-Tai, T., Chern-En, C., Lee, S., Chiou, C.-W., Kwo-Chang, U., Zu-Chi, W., Wen-Chung, Y., Chen, Y., et al. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00648-0 · Cited by 37
Brembilla-Perrot, B., Chometon, F., Groben, L., Ammar, S., Bertrand, J., Marcha, C., Cloez, J. L., Tisserand, A., Huttin, O., Tatar, C., et al. (2007) · EP Europace · doi:10.1093/europace/eum153 · Cited by 36
Tijunelis, M. A., & Herbert, M. (2005) · Canadian Journal of Emergency Medicine · doi:10.1017/s148180350001441x · Cited by 36
“2), which occurs in 10%–23% of patients with WPW(4) and places the patient at significantly higher risk of spontaneous ventricular fibrillation.(5,6) Patients with ECG manifestations of pre-excitation should have a cardiology evaluation because prophylactic accessory-pathway ablation has been shown to reduce the frequ…”
BackgroundWhen should we recommend catheter ablation for patients with the Wolff–Parkinson–White syndrome?
Tischenko, A., Fox, D. J., Yee, R. K., Krahn, A. D., Skanes, A. C., Gula, L. J., & Klein, G. J. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282f26d1b · Cited by 34
Aytemir, K., Amasyalı, B., Köse, S., Kılıç, A., Abalı, G., Oto, A., & Işık, E. (2004) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/b:jice.0000035925.90831.80 · Cited by 34
Catheter Ablation Therapy for Supraventricular Arrhythmias
Marine, J. E. (2007) · JAMA · doi:10.1001/jama.298.23.2768 · Cited by 32
Supraventricular tachyarrhythmia as a cause of sudden cardiac arrest
Brembilla-Perrot, B., Marçon, O., Chometon, F., Bertrand, J., Chaise, A. T. D. L., Louis, P., Belhakem, H., Blangy, H., Claudon, O., Selton, O., et al. (2006) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-006-9042-4 · Cited by 30
“02%/patient/ year in asymptomatic patients [18, 19].”
Long term risk of Wolff-Parkinson-White pattern and syndrome
Kim, S. S., & Knight, B. P. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.12.001 · Cited by 34
Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010)
JCS Joint Working Group (2012) · Circulation Journal · doi:10.1253/circj.cj-88-0022 · Cited by 31
Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality
Skov, M. W., Rasmussen, P. V., Ghouse, J., Hansen, S. M., Graff, C., OLESEN, M. S., Pietersen, A. H., Torp-Pedersen, C. T., Haunsø, S., Køber, L., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004778 · Cited by 28
Oddsson, H. (2002) · EP Europace · doi:10.1053/eupc.2002.0223 · Cited by 27
Risk Factors of Adverse Presentation as the First Arrhythmia in Wolff-Parkinson-White Syndrome
Brembilla-Perrot, B., Tatar, C., & Selton‐Suty, C. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02782.x · Cited by 25
Wolf–Parkinson–White Syndrome: Diagnosis, Risk Assessment, and Therapy—An Update
Vatasescu, R. G., Paja, S.-C., Şuş, I., Cainap, S. S., Moisă, Ș. M., & Cinteză, E. E. (2024) · Diagnostics · doi:10.3390/diagnostics14030296 · Cited by 36
Perez, M. V., Fonda, H., Le, V., Mitiku, T. Y., Ray, J. W., Freeman, J. V., Ashley, E. A., & Froelicher, V. F. (2009) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2009.08.002 · Cited by 25
Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010) : Digest Version
Aizawa, Y., Horie, M., Inoue, H., Kamakura, S., Katoh, T., Matsuzaki, M., Misaki, T., Mitamura, H., Murakawa, Y., Nitta, T., et al. (2012) · Institutional Repositories DataBase (IRDB) · Cited by 24
Sra, J. S., Dhala, A. A., Blanck, Z., Deshpande, S., Cooley, R., & Akhtar, M. (1999) · Current Problems in Cardiology · doi:10.1016/s0146-2806(99)90004-x · Cited by 27
Niwano, S., Yamaura, M., Washizuka, T., Tanabe, Y., Furushima, H., Taneda, K., & Aizawa, Y. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00011.x · Cited by 24
Clinical magnetocardiography: 10 Years experience at the catholic university
Fenici, R. R., Melillo, G., & Masselli, M. (1991) · The International Journal of Cardiac Imaging · doi:10.1007/bf01797748 · Cited by 23
Electrocardiographic and Clinical Precursors of Ventricular Fibrillation: Chain of Events
Bayés‐Genís, A., Viñolas, X., Soldevila, J. G., Fiol, M., & Bayés‐Genís, A. (1995) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1995.tb00415.x · Cited by 23
Self-citationMissing diagnosis of preexcitation syndrome on ECG
Brembilla-Perrot, B., Valizadeh-Moejezi, R., Zinzius, P. Y., Jarmouni, S., Schwartz, J., Beurrier, D., Sellal, J., Nossier, I., Mureşan, L., Andronache, M., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.051 · Cited by 21
“Sudden death may be caused by unusually atrial fibrillation conducted very fast by an AP with degeneration into ventricular fibrillation [23–25]; sudden death could be the first event in the evolution of this syndrome.”
BackgroundApproach to the patient with palpitations
Weitz, H. H., & Weinstock, P. J. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30078-5 · Cited by 23
Chevalier, P., Cadi, F., Scridon, A., Girerd, N., Bejan‐Angoulvant, T., Morel, É., Hot, I. J., Filippo, S. D., Ganne, C., & Colin, C. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.970459 · Cited by 22
de Rosales, F. M., Moreno, J., Bodegas, A., Melchor, J. C., Fernández‐Llebrez, L., & Aranguren, G. (1994) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(94)90155-4 · Cited by 21
Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease
Lundqvist, C. B., Potpara, T., & Malmborg, H. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:29:3 · Cited by 20
“• Short R-R interval (<250 ms) during spontaneous or induced AF; • History of symptomatic tachycardia; • Multiple accessory pathways; • Ebstein’s anomaly.(42,43)”
BackgroundWolff-Parkinson-White syndrome in the elderly: clinical and electrophysiological findings
Brembilla-Perrot, B., N’Da’, O. Y., Huttin, O., Chometon, F., Groben, L., Christophe, C., Benzaghou, N., Luporsi, J. D., Tatar, C., Bertrand, J., et al. (2008) · Archives of cardiovascular diseases · doi:10.1016/s1875-2136(08)70250-x · Cited by 21
Therapy of Wolff‐Parkinson‐White Syndrome and Concealed Bypass Tracts: Part I
Miller, J. M. (1996) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1996.tb00464.x · Cited by 21
Ventricular fibrillation risk factors in over one thousand patients with accessory pathways
Orczykowski, M., Walczak, F., Derejko, P., Bodalski, R., Urbanek, P., Zakrzewska‐Koperska, J., Przybylski, A., Kępski, R., Jedynak, Z., Maryniak, A., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.076 · Cited by 19
“[2,10], although ACC/AHA/ESC [8] guidelines do not itemize the parameter of AF occurrence but that of SPRR b250 ms.”
BackgroundAsymptomatic Ventricular Pre-excitation: Between Sudden Cardiac Death and Catheter Ablation
Brugada, J., & Keegan, R. O. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2017.51.2 · Cited by 18
“05).(41) Added to this, the risk of SCD in female patients was markedly lower than in male patients in a recent meta-analysis.”
ResultBrembilla-Perrot, B., Chometon, F., Groben, L., Tatar, C., Luporsi, J. D., Bertrand, J., Huttin, O., Beurrier, D., Ammar, S., Cedano, J., et al. (2008) · EP Europace · doi:10.1093/europace/eum300 · Cited by 18
JCS / JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia
Takase, B., Ikeda, T., Shimizu, W., Abe, H., Aiba, T., Chinushi, M., Koba, S., KUSANO, K. F., Niwano, S., Takahashi, N., et al. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13052 · Cited by 19
Sudden Cardiac Death in Patients with Ventricular Preexcitation
Delise, P., & Sciarra, L. (2020) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.08.002 · Cited by 17
Jung, H. J., Ju, H. Y., Hyun, M. C., Lee, S. B., & Kim, Y. H. (2011) · Korean Journal of Pediatrics · doi:10.3345/kjp.2011.54.12.507 · Cited by 15
Sudden Death in Pediatric Populations
Wu, M. (2010) · Korean Circulation Journal · doi:10.4070/kcj.2010.40.6.253 · Cited by 15
Ig, M., Filho, F. E. D. S. C., Fagundes, M., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00317-7 · Cited by 15
A Functional Approach to the Preexcitation Syndromes
Oren, J. W., Beckman, K. J., McClelland, J. H., Wang, X., Lazzara, R., & Jackman, W. M. (1993) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30196-6 · Cited by 14
Sudden Death and Ventricular Preexcitation: Is it Necessary to Treat the Asymptomatic Patients?
Pappone, C., Radinovic, A., & Santinelli, V. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784007662 · Cited by 14
Jaalouk, D. E., Ozawa, M. G., Sun, J. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2737 · Cited by 14
Skanes, A. C., Obeyesekere, M., & Klein, G. J. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.05.002 · Cited by 13
Ren, J., Yang, Y., Zhu, J., Wu, S., Wang, J., Zhang, H., & Shao, X. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14113 · Cited by 14
Intermittent Preexcitation: Should We Rethink the Current Guidelines?
Cohen, M. I. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12745 · Cited by 13
Risk of atrial fibrillation according to the initial presentation of a preexcitation syndrome
Brembilla-Perrot, B., Popescu, I., Huttin, O., Zinzius, P. Y., Mureşan, L., Jarmouni, S., Nossier, I., Schwartz, J., Sellal, J., Beurrier, D., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.12.078 · Cited by 13
Electrophysiological evaluation of Wolff-Parkinson-White syndrome.
Brembilla-Perrot, B. (2002) · PubMed · Cited by 13
2025 Clinical practice guidelines for Supraventricular tachycardias
Popov, S. V., Davtyan, K. V., Shubik, Y. V., Artyukhina, Е. А., Базаев, В. А., Batalov, R. E., Bokeria, L. A., Bubnova, M. G., Vygovsky, A. B., Sp, G., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6448 · Cited by 12
Clinical and electrophysiological evaluation of pediatric Wolff-Parkinson-White patients
Yıldırım, I., Özer, S., Karagöz, T., Şahin, M., Özkutlu, S., Alehan, D., & Çeliker, A. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5462 · Cited by 12
“1-18) years), and 14 presented with syncope (median age 12 (6-16) years); 13 were asymptomatic (median age 10 (2-13) years).”
BackgroundInfluentialReview paper on WPW and athletes: Let sleeping dogs lie?
Leung, L. W. M., & Gallagher, M. M. (2020) · Clinical Cardiology · doi:10.1002/clc.23399 · Cited by 12
Causas de muerte súbita. Problemas a la hora de establecer y clasificar los tipos de muerte
Font, E. R., & Viñolas, X. (1999) · Revista Española de Cardiología · doi:10.1016/s0300-8932(99)75027-x · Cited by 17
Leoni, L., Bronzetti, G., Colonna, D., Porcedda, G., Rimini, A., & Silvetti, M. S. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001484 · Cited by 12
Management of symptomatic Wolff–Parkinson–White syndrome in childhood
Tsao, S. S. L., & Deal, B. J. (2012) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2012.11.002 · Cited by 11
“Cardiac arrestmaybe the initial presenting symptom,particularly among young patients, where almost 50% had no prior cardiac symptoms [6,56,57].”
BackgroundBrembilla-Perrot, B., Houriez, P., Beurrier, D., Louis, P., Boursier, M., & Khalifé, K. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.t01-1-00266.x · Cited by 11
Erdoğan, İ., Özer, S., Karagöz, T., Şahin, M., & Çeliker, A. (2009) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2009.2360 · Cited by 10
HSIEH, M., TAI, C., Chiang, C., et al. (2004) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/b:jice.0000042347.27095.b4 · Cited by 11
Guidelines for Management of Asymptomatic Ventricular Pre-excitation
Cohen, M. I., & Triedman, J. K. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001528 · Cited by 11
Pauriah, M., Cismaru, G. L., Sellal, J., de Chillou, C., & Brembilla-Perrot, B. (2013) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2012.12.019 · Cited by 10
Age‐Related Prognosis of Syncope Associated with a Preexcitation Syndrome
Brembilla-Perrot, B., Moulin-Zinsch, A., Sellal, J., Zinzius, P. Y., Schwartz, J., Beurrier, D., de Chillou, C., Godenir, J. P., Lethor, J. P., MARCHAL, C., et al. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12110 · Cited by 10
Sudden death in a child with an unusual accessory connection
Heaven, D. (2000) · EP Europace · doi:10.1053/eupc.2000.0101 · Cited by 10
“However, these findings are not specific and have a low predictive value([1,7,8]).”
BackgroundKoca, S., Paç, F. A., Kavurt, A. V., Çay, S., Mıhçıoğlu, A. M., Aras, D., & Topaloğlu, S. (2017) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13100 · Cited by 10
Use of medications in Wolff-Parkinson-White syndrome
Redfearn, D., Krahn, A. D., Skanes, A. C., Yee, R. K., & Klein, G. J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.6.955 · Cited by 10
Tratamiento de los pacientes con preexcitación ventricular
Garrote, J. A., Torrecilla, E. G., Atienza, F., Escribano, D. V., & Arenal, Á. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77206-1 · Cited by 9
Brembilla-Perrot, B., Sellal, J., Olivier, A., Manenti, V., Beurrier, D., Jouma, B. A., Andronache, M., de Chillou, C., Girerd, N., & Villemin, T. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.114 · Cited by 7
“The risk is low [2–6] and estimated to be of 0.”
BackgroundVentricular fibrillation during electrical cardioversion of pre-excited atrial fibrillation
Adlam, D., & Azeem, T. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.931.297 · Cited by 9
Intermittent ventricular pre‐excitation in symptomatic adults: Always a marker of low risk?
Robles, A. G., Palamà, Z., Pernat, A., Gianfrancesco, D., Bartolomucci, F., Scarà, A., Borrelli, A., Ruvo, E. D., Calò, L., Penco, M., et al. (2023) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14798 · Cited by 8
Metadata
- Authors
- TORNER, P., BRUGADA, P., SMEETS, J., TALAJIC, M., DELLA BELLA, P., LEZAUN, R., DOOL, A. V. D., WELLENS, H. J. J., DE LUNA, A. B., OTER, R., BREITHARDT, G., BORGGREFE, M., KLEIN, H., KUCK, K. H., KUNZE, K., COUMEL, P., LECLERCQ, J. F., CHOUTY, F., FRANK, R., & FONTANINE, G.
- Affiliations
- Maastricht University Medical Centre (NL)
- Düsseldorf University Hospital (DE)
- Medizinische Hochschule Hannover (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Hôpital Lariboisière (FR)
- Centre Hospitalier Jean-Rostand (FR)
- Corresponding author
- BRUGADA, P.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-02
- Volume
- 12
- Issue
- 2
- Pages
- 144-150
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2317531844
- Cited by
- 206
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 9 · 2016: 2 · 2015: 5 · 2014: 9 · 2013: 13 · 2012: 16
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- ventricular fibrillation, Wolff-Parkinson-White syndrome, accessory pathway, anterograde conduction, ventricular effective refractory period, supraventricular tachycardia, atrial fibrillation, multiple accessory pathways, preexcitation
- MeSH terms
- Adult, Atrial Fibrillation, Cardiac Pacing, Artificial, Echocardiography, Electrocardiography, Exercise Test, Female, Heart Conduction System, Humans, Male, Retrospective Studies, Ventricular Fibrillation, Wolff-Parkinson-White Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
